| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
steroid 5 alpha-reductase 2 | 0.564 | 0.615 |
|
group | 0.400 | None | 1.000 | 20 | 0 | 2000 | 2015 | |||||||||
|
telomerase RNA component | 0.471 | 0.846 |
|
disease | 0.700 | None | 1.000 | 9 | 0 | 2001 | 2019 | |||||||||
|
DAOA antisense RNA 1 | 0.729 | 0.154 |
|
disease | 0.400 | None | 1.000 | 7 | 0 | 2004 | 2014 | |||||||||
|
KCNQ1 opposite strand/antisense transcript 1 | 0.534 | 0.731 |
|
disease | 0.600 | None | 0.981 | 6 | 0 | 1999 | 2018 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2002 | 2008 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2009 | |||||||||
|
ribonuclease A family member 3 | 0.490 | 0.808 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1996 | 2019 | |||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
group | 0.100 | None | 1.000 | 4 | 0 | 2006 | 2018 | |||||||||
|
prostate cancer associated 3 | 0.663 | 0.615 |
|
group | 0.090 | None | 1.000 | 4 | 0 | 2002 | 2017 | |||||||||
|
inflammatory bowel disease 5 | 0.705 | 0.538 |
|
disease | 0.100 | None | 0.913 | 4 | 0 | 2001 | 2012 | |||||||||
|
telomerase RNA component | 0.471 | 0.846 |
|
disease | 0.180 | None | 1.000 | 4 | 0 | 2003 | 2019 | |||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2002 | 2019 | |||||||||
|
cancer/testis antigen 1B | 0.507 | 0.731 |
|
disease | 0.080 | None | 1.000 | 3 | 0 | 2003 | 2019 | |||||||||
|
defensin alpha 1 | 0.636 | 0.731 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2008 | |||||||||
|
H19 imprinted maternally expressed transcript | 0.494 | 0.923 |
|
disease | 0.600 | limited | 0.950 | 3 | 0 | 1994 | 2017 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 0.983 | 3 | 0 | 1986 | 2020 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1990 | 2019 | |||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.700 | None | 0.939 | 3 | 0 | 2007 | 2020 | |||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1992 | 2017 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
disease | 0.040 | None | 0.750 | 3 | 0 | 2004 | 2006 | |||||||||
|
microRNA 122 | 0.468 | 0.808 |
|
disease | 0.100 | None | 0.974 | 3 | 0 | 2007 | 2020 | |||||||||
|
microRNA 122 | 0.468 | 0.808 |
|
disease | 0.400 | None | 0.993 | 3 | 0 | 2006 | 2020 | |||||||||
|
MAGE family member A3 | 0.588 | 0.500 |
|
disease | 0.100 | None | 0.958 | 3 | 0 | 1994 | 2018 | |||||||||
|
MAGE family member A3 | 0.588 | 0.500 |
|
disease | 0.390 | None | 1.000 | 3 | 0 | 1999 | 2020 | |||||||||
|
NADH dehydrogenase, subunit 3 (complex I) | 0.604 | 0.654 |
|
disease | 0.490 | None | 1.000 | 3 | 0 | 2001 | 2019 |